Search Results - "van Schoubroeck, H."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Cost-effectiveness of abemaciclib in early breast cancer patients: one size fits all or tailoring to patients’ needs

    Cost-effectiveness of abemaciclib in early breast cancer patients: one size fits all or tailoring to patients’ needs by Jongbloed, L., Blommestein, H.M., van Schoubroeck, H., Martens, J.W.M., Wilting, S.M., Uyl-de Groot, C.A., Jager, A.

    Published in European journal of cancer (1990) (01-11-2022)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    CO69 A Systematic Literature Review (SLR) of the Clinical Evidence for Treatment of Differentiated Thyroid Cancer (DTC) After Prior Systemic Therapy

    CO69 A Systematic Literature Review (SLR) of the Clinical Evidence for Treatment of Differentiated Thyroid Cancer (DTC) After Prior Systemic Therapy by Houchard, A, Kreissl, M, Tham, M, van Schoubroeck, H, Rekowska, D, Nientker, L, Leboulleux, S

    Published in Value in health (01-12-2022)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients' Needs?

    Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients' Needs? by Jongbloed, Elisabeth M, Blommestein, Hedwig M, van Schoubroeck, Hannah M, Martens, John W M, Wilting, Saskia M, Uyl-de Groot, Carin A, Jager, Agnes

    Published in Breast cancer targets and therapy (01-01-2023)
    “…The addition of two years of abemaciclib treatment to standard adjuvant endocrine therapy in all patients with high risk ER+, HER2- early breast cancer (EBC)…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: